Trial Profile
A prospective, observational study of mirabegron in women with overactive bladder symptoms
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Feb 2017
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 15 Feb 2017 New trial record